CME/CE: Dronedarone in Middle Age Linked to More Admissions
By: Alere Staff
American Heart Association
April 3, 2015 – April 3, 2017
Physicians: 0.25 AMA PRA Category 1 Credit(s) ™
Treatment with dronedarone (Multaq) was associated with a higher risk for hospitalization than treatment with amiodarone or other antiarrhythmic drugs, in an observational study involving nongeriatric atrial fibrillation (Afib) patients without cardiovascular disease.